These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5614 related articles for article (PubMed ID: 3744640)

  • 21. The influence of cyclophosphamide on antibody formation in the mouse.
    Willers JM; Sluis E
    Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidiabetic activity of levan polysaccharide in alloxan-induced diabetic rats.
    Dahech I; Belghith KS; Hamden K; Feki A; Belghith H; Mejdoub H
    Int J Biol Macromol; 2011 Nov; 49(4):742-6. PubMed ID: 21782842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of the inhibitory effect of levan on experimental tumors.
    Leibovici J; Stark Y; Eldar T; Brudner G; Wolman M
    Recent Results Cancer Res; 1980; 75():173-9. PubMed ID: 7232830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Slow cytotoxicity of the polysaccharide levan on tumor cells in vitro.
    Leibovici J; Stark Y
    Chem Biol Interact; 1986 Nov; 60(2):191-200. PubMed ID: 3791487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dioscorea bulbifera polysaccharide and cyclophosphamide combination enhances anti-cervical cancer effect and attenuates immunosuppression and oxidative stress in mice.
    Cui H; Li T; Wang L; Su Y; Xian CJ
    Sci Rep; 2016 Jan; 5():19185. PubMed ID: 26753518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response relationships of cytotoxicity, PFC response and histology in the spleen in rats treated with alkylating agents.
    Doi T; Nagai H; Tsukuda R; Suzuki T
    Toxicology; 1996 Jan; 107(1):47-60. PubMed ID: 8597031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclophosphamide-mediated enhancement of antitumor immune potential of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor.
    Mokyr MB; Colvin M; Dray S
    Int J Immunopharmacol; 1985; 7(1):111-22. PubMed ID: 3922904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different stages of tumor development are unequally affected by pretreatment of tumor cells with a polysaccharide.
    Michowitz M; Stark Y; Leibovici J
    Cancer Lett; 1984 Jul; 23(3):343-9. PubMed ID: 6744256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of cyclophosphamide-induced elimination of lymphocytes from the spleen and lymph node on immune response in mice.
    Konys J; Mackiewicz U; Drygas J
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):783-8. PubMed ID: 7349098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of suppressor cells in the bone marrow and spleens of high dose cyclophosphamide-treated C57Bl/6 mice.
    Nikcevich DA; Duffie GP; Young MR; Ellis NK; Kaufman GE; Wepsic HT
    Cell Immunol; 1987 Oct; 109(2):349-59. PubMed ID: 2959374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation and suppression of graft-vs-host reactions by cyclophosphamide.
    Wander RH; Hilgard HR
    J Immunol; 1981 Mar; 126(3):901-4. PubMed ID: 7462635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro effect of levan-activated macrophages on Lewis lung carcinoma cells.
    Leibovici J; Hoenig S; Pinchassov A
    Int J Immunopharmacol; 1986; 8(5):471-8. PubMed ID: 3759297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adoptively transferred ex vivo activated memory T cells with cyclophosphamide: effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
    Gold JE; Zachary DT; Osband ME
    Clin Immunol Immunopathol; 1994 Oct; 73(1):115-22. PubMed ID: 7923908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of Muramylpeptides from Gram-Negative Bacteria Corrects Cyclophosphamide-Induced Disorders of Hematopoiesis and Spleen Cell Composition in Mice with B16 Melanoma.
    Kiselevskii MV; Anisimova NY; Sitdikova SM; Donenko FV; L'vov VL; Kalyuzhin OV; Nurtazina AY; Karaulov AV
    Bull Exp Biol Med; 2021 Apr; 170(6):782-786. PubMed ID: 33893966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct antitumor effect of high-molecular-weight levan on Lewis lung carcinoma cells in mice.
    Leibovici J; Susskind-Brudner G; Wolman M
    J Natl Cancer Inst; 1980 Aug; 65(2):391-6. PubMed ID: 6931256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Separate and combined effects of ionizing radiation and cyclophosphamide on thymus-dependent humoral immune response].
    Sharetskiĭ AN; Surinov BP; Abramova MR
    Radiats Biol Radioecol; 1998; 38(5):696-700. PubMed ID: 9876494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the in vitro concanavalin A response of lymphocytes by cyclophosphamide-sensitive adherent cells--a possible role of Cy-sensitive regulatory cells.
    Ikezawa Z
    Jpn J Exp Med; 1980 Aug; 50(4):225-35. PubMed ID: 7441904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A polysaccharide from Strongylocentrotus nudus eggs protects against myelosuppression and immunosuppression in cyclophosphamide-treated mice.
    Wang H; Wang M; Chen J; Tang Y; Dou J; Yu J; Xi T; Zhou C
    Int Immunopharmacol; 2011 Nov; 11(11):1946-53. PubMed ID: 21723424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of the effects of cyclophosphamide on the lymphoid system of mice by double-stranded RNA.
    Sůla K; Nouza K
    Folia Biol (Praha); 1985; 31(1):59-62. PubMed ID: 2578997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of a single dose of cyclophosphamide on T cell subsets of the thymus and spleen in mice: flow cytofluorometry analysis.
    Miyauchi A; Hiramine C; Tanaka S; Hojo K
    Tohoku J Exp Med; 1990 Oct; 162(2):147-67. PubMed ID: 2129070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 281.